METRONIDAZOLE INJECTION
As listed in the register: METRONIDAZOLE INJECTION, USP
5 mg · solution
- Prescription only
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Metronidazole
- Made by
- Baxter Corporation
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Metronidazole). It describes the substance, not this exact product.
Disposition of metronidazole in the body is similar for both oral and intravenous dosage forms.
Following oral administration, metronidazole is well absorbed, with peak plasma concentrations occurring between one and two hours after administration.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-26
Safety of the active substance
From the US prescribing label for the same active substance (Metronidazole). It describes the substance, not this exact product.
WARNING Metronidazole has been shown to be carcinogenic in mice and rats (see PRECAUTIONS ).
- Hypersensitivity Metronidazole tablet are contraindicated in patients with a prior history of hypersensitivity to metronidazole or other nitroimidazole derivatives.
- In patients with trichomoniasis, metronidazole tablet are contraindicated during the first trimester of pregnancy (see PRECAUTIONS ).
- Psychotic Reaction with Disulfiram Use of oral metronidazole is associated with psychotic reactions in alcoholic patients who were using disulfiram concurrently.
- Do not administer metronidazole to patients who have taken disulfiram within the last two weeks (see PRECAUTIONS, Drug Interactions ).
The most common adverse reactions reported have been referable to the gastrointestinal tract, particularly nausea, sometimes accompanied by headache, anorexia, and occasionally vomiting; diarrhea; epigastric distress; and abdominal cramping and constipation.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Baxter Corporation |
|---|---|
| Active substance | Metronidazole |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 5 mg |
| Form | solution |
| Classification | J01XD01 · Antibiotics, antivirals and antifungals taken into the body |
| Route | intravenous |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| Name in the register | METRONIDAZOLE INJECTION, USP |
| DIN | 00870420 |
| DPD drug code | 10871 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.